Muller TD, Sullivan LM, Habegger K, Yi CX, Kabra D, Grant E et al
You may request access to, correction of, or deletion of your personal information at any time in accordance with applicable privacy laws, including the California Consumer Privacy Act (CCPA/CPRA) where applicable
Retatrutide is a once-weekly injection that mimics three hormones involved in appetite, blood sugar, and how the body uses energy: GLP-1: lowers appetite and blood sugar GIP: lowers appetite and blood sugar Glucagon: increases energy expenditure and the breakdown of stored fat, including fat in the liver The glucagon component is what separates retatrutide from semaglutide, which mimics one hormone (GLP-1), and tirzepatide, which mimics two (GLP-1 and GIP)
Still, clinical decisions depend on approval status, product labeling, side effects, diabetes treatment goals, cardiovascular risk, comorbid conditions, and patient preferences